Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.
Highly active antiretroviral therapy (HAART) has changed the face of human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS) by leading to dramatic decreases in HIV-related morbidity and mortality in the developed as well as developing world. Since the introduction of HAART, the incidence of ocular opportunistic infections causing retinitis has dramatically decreased, and clinicians should be aware of changes in the clinical presentation of ocular manifestations of HIV. As studies of HIV disease after the introduction of HAART continue to become available, more thorough descriptions of treated patients with ocular opportunistic infections will include side-effects and toxicities of therapy. This review focuses on the impact of HAART on the ocular manifestations of HIV.
Venkatesh
Kartik K
KK
Brown University Medical School, Providence, RI, USA.
Biswas
J
J
Kumarasamy
N
N
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015828:Eye Infections, Viral / Q000188:drug therapy* / Q000453:epidemiology; D014943:Global Health; D006801:Humans; D009017:Morbidity; D016896:Treatment Outcome